Specialty Pharmacy

Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.

Strategic tips for pharma to develop an overall business strategy around digital engagement.

Trastuzumab-dkst (Ogivri) is the second biosimilar approved for cancer.

Patients with a partner were nearly twice as likely to finish 6 months of chemotherapy for colon cancer.

Moses Zonana, CEO of Compliance Meds Technologies, discusses the impact of medication nonadherence.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Raltegravir (Isentress) is an integrase inhibitor for use in combination with other antiretroviral agents for HIV-1 in newborn infants weighing at least 2 kg.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Millions of individuals gain access to HIV treatment, but there are significant gaps that need to be addressed to end the epidemic.

A new system allows researchers to test multiple drug combinations in cultured cancer stem cells from patients.

Top news of the day from across the health care landscape.

Multiple sclerosis researchers actively seek new agents than can promote repair and remyelination.

High oncology drug costs could impact adherence to cancer treatment.

Closing gaps in testing at-risk populations could increase HIV diagnoses.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how Walgreens has encouraged their pharmacists to continue their education.

Top news of the day from across the health care landscape.

A lack of physical activity leads to a higher risk of depression among patients with rheumatic diseases.

Increasing collaboration among providers could improve medication adherence and patient outcomes.

Proposed changes to Medicare Part D take aim at potentially harmful PBM practices.

Adipocytes were observed to absorb and metabolize daunorubicin chemotherapy in leukemia cells.

Mastectomy for early-stage breast cancer increases the risk of missing more than 1 month of work.

Top news from across the health care landscape.

Increased virologic failure and drug resistance following dolutegravir monotherapy prompt researchers to recommend against its use in patients with HIV.

Pharmacists have an obligation to counsel patients effectively on medications with risk evaluation mitigation strategy.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what considerations must be made to create a care management program in the specialty space.

A mathematical model could reduce unnecessary immunotherapy treatment.

Novel predictive model harnesses technology to diagnose ovarian cancer more accurately than ultrasound.